The Last Line of Defense Against Counterfeit Drugs

Recently, there has been talk in our nation’s Capitol about overhauling the Food and Drug Administration’s (FDA) presence both in the United States and abroad. This is an important step in improving the safety of prescription medications from the global public health threat of counterfeit drugs and the untold harm they cause unsuspecting consumers. But, with limited budget and resources, will the FDA be able to pull off the task?

[...]